<?xml version="1.0" encoding="UTF-8"?>
<ref id="R93">
 <label>93</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Bonam</surname>
    <given-names>SR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kaveri</surname>
    <given-names>SV</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sakuntabhai</surname>
    <given-names>A</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Adjunct immunotherapies for the management of severely ill COVID-19 patients</article-title>. 
  <source>Cell Rep Med</source>
  <year>2020</year>;
  <volume>1</volume>:
  <fpage>100016</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.xcrm.2020.100016</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32562483?>
  <pub-id pub-id-type="pmid">32562483</pub-id>
 </mixed-citation>
</ref>
